An integrated strategy for the discovery of drug targets by the analysis of protein-protein interactions

被引：3

作者：

Peltier, JM ^{[1
]}

Askovic, S ^{[1
]}

Becklin, RR ^{[1
]}

Chepanoske, CL ^{[1
]}

Ho, YSJ ^{[1
]}

Kery, V ^{[1
]}

Lai, SP ^{[1
]}

Mujtaba, T ^{[1
]}

Pyne, M ^{[1
]}

Robbins, PB ^{[1
]}

von Rechenberg, M ^{[1
]}

Richardson, B ^{[1
]}

Savage, J ^{[1
]}

Sheffield, P ^{[1
]}

Thompson, S ^{[1
]}

Weir, L ^{[1
]}

Widjaja, K ^{[1
]}

Xu, NF ^{[1
]}

Zhen, YJ ^{[1
]}

Boniface, JJ ^{[1
]}

机构：

[1] Prolexys Pharmaceut Inc, Salt Lake City, UT 84116 USA

来源：

INTERNATIONAL JOURNAL OF MASS SPECTROMETRY | 2004年 / 238卷 / 02期

关键词：

protein interactions; MS/MS; affinity tags; drug discovery; drug targets;

D O I：

10.1016/j.ijms.2003.12.039

中图分类号：

O64 [物理化学（理论化学）、化学物理学]; O56 [分子物理学、原子物理学];

学科分类号：

070203 ; 070304 ; 081704 ; 1406 ;

摘要：

Proteomics-based technologies have the potential to accelerate the development of drugs, but such technologies must be well integrated in order to have a positive impact. We describe, herein, a multi-step process for the discovery of protein-protein interactions. It is shown that process stages are interdependent and can influence, either positively or negatively, subsequent steps. Optimization of each step, in the context of the full process, is essential for the overall success of the experiment. (C) 2004 Elsevier B.V. All rights reserved.

引用

页码：119 / 130

页数：12

共 50 条

[31] Virus-host protein-protein interactions as molecular drug targets for arboviral infections
Bhutkar, Mandar
Singh, Vishakha
Dhaka, Preeti
Tomar, Shailly
FRONTIERS IN VIROLOGY, 2022, 2
[32] Targeting protein-protein interactions as an anticancer strategy
Ivanov, Andrei A.
Khuri, Fadlo R.
Fu, Haian
TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (07) : 393 - 400
[33] Protein microarrays as a discovery tool for studying protein-protein interactions
Korf, U
Wiemann, S
EXPERT REVIEW OF PROTEOMICS, 2005, 2 (01) : 13 - 26
[34] Kinases versus protein-protein interactions: Different opportunities and challenges in drug discovery.
Garcia-Echeverria, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U470 - U470
[35] Fragment-based drug discovery supports drugging 'undruggable' protein-protein interactions
Wang, Zhi-Zheng
Shi, Xing-Xing
Huang, Guang-Yi
Hao, Ge-Fei
Yang, Guang-Fu
TRENDS IN BIOCHEMICAL SCIENCES, 2023, 48 (06) : 539 - 552
[36] Exploring macrocycles for drug discovery: Novel lead series for challenging protein-protein interactions
Terrett, Nick
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[37] Small-Molecule Stabilization of Protein-Protein Interactions: An Underestimated Concept in Drug Discovery?
Thiel, Philipp
Kaiser, Markus
Ottmann, Christian
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (09) : 2012 - 2018
[38] Targeting Protein-Protein Interactions: A Promising Avenue of Anti-HIV Drug Discovery
Zhan, Peng
Li, Wenjun
Chen, Hongfei
Liu, Xinyong
CURRENT MEDICINAL CHEMISTRY, 2010, 17 (29) : 3393 - 3409
[39] A comprehensive dataset of protein-protein interactions and ligand binding pockets for advancing drug discovery
Moine-Franel, Alexandra
Mareuil, Fabien
Nilges, Michael
Ciambur, Constantin Bogdan
Sperandio, Olivier
SCIENTIFIC DATA, 2024, 11 (01)
[40] Construction of a cancer-perturbed protein-protein interaction network for discovery of apoptosis drug targets
Chu, Liang-Hui
Chen, Bor-Sen
BMC SYSTEMS BIOLOGY, 2008, 2

← 1 2 3 4 5 →